Abstract:Purpose: To detect elements governing the pathogenesis of diabetic cystopathy (DC), mRNA sequencing was carried out for bladder tissues from normal rats and those with induced diabetes mellitus (DM). This research therefore offers possible underlying molecular pathways for the advancement of DC in relation to differential mRNA expression, together with visceral functional and architectural alterations noted in individuals with this condition. Methods: An intraperitoneal injection of streptozotocin (STZ) was utilized to provoke DM in male Sprague-Dawley rats. Dysregulation and significant variations between normal rats and those with induced DM were then identified by a fold change of ≥ 1.5 with a false discovery rate P < 0.05. Hierarchical clustering/heat map and Gene Ontology/DAVID reference sources were generated. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and protein-protein interaction analysis were then performed. Results: The diabetic rodent group exhibited a greater residual urine volume (4.0 ± 0.4 mL) than their control counterparts (0.7 ± 0.2 mL, P < 0.01) at 12 weeks after diagnosis of diabetes. Expression analysis revealed 16 upregulated and 4 downregulated genes in STZDM bladder samples. A notable increase in expression was seen in PTHLH, TNFAIP6, PRC1, MAPK10, LOC686120, CASQ2, ACTG2, PDLIM3, FCHSD1, DBN1, NKD2, PDLIM7, ATF4, RBPMS2, ITGB1 and HSPB8. A notable decrease in expression was seen in SREBLF1, PBGFR1, PBLD1 and CELF1. Major genetic themes associated with mRNA upregulation and downregulation ware identified via Gene Ontology analysis and KEGG pathways. Protein to protein interaction analysis detected PDLIM3, PDLIM7, ITGB1, ACTG2 as core high frequency nodes within the network. Conclusion: Changes in mRNA expression together with biological process and pathways that contribute to the etiologies underlying visceral impairment of the bladder in DM are evident. Our strategy is promising for recognizing mRNAs exclusive to the bladder in DM that might offer useful targets for diagnosis and treatment.

Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model.

A2B Adenosine Receptor Agonist Improves Erectile Function in Diabetic Rats

Molecular biology investigation of diabetes cystopathy in rats:relationship beween bladder relaxation characters and 3-adrenergic receptor level

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats.

The Starling mechanism of the urinary bladder contractile function and the influence of hyperglycemia on diabetic rats

Impaired capsaicin-induced relaxation in diabetic mesenteric arteries

Effects of Electroacupuncture on Bladder Dysfunction and the Expression of PACAP38 in a Diabetic Rat Model.

Expression of Transforming Growth Factor Beta1 Gene, Basic Fibroblast Growth Factor Gene and Hydroxyproline in Diabetes-Induced Bladder Dysfunction in a Rat Model.

Changes in Alpha1-Adrenoceptor and NGF/proNGF Pathway: a Possible Mechanism in Diabetic Urethral Dysfunction.

Functional, Structural, and Neuronal Alterations in Urinary Bladder during Diabetes: Investigations of a Mouse Model

Studies on Effect of Diabetes Mellitus on Detrusor Excitability,contractility and Compliance in Diabetic Rat

The Function of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel in Diabetic Cystopathy.

Expression of NGF in Lumbar Dorsal Root Ganglia and Bladder of Diabetic Rats and Urodynamic Changes

IKCa in Cavernous Tissue of Rat Models of Diabetes Mellitus

Improvement of Urethral Dysfunction by 5‐HT1A Receptor Agonist NLX‐112 in Diabetic Rats

Streptozotocin-induced Diabetes Causes Upregulation of Serotonin (5-HT)2A/C Receptors in Lumbosacral Cord Motoneurons and Down Regulation of Serotonergic Paraneurons in the Urethra.

Serotonin (5-HT) 2A/2C Receptor Agonist (2,5-Dimethoxy-4-idophenyl)-2-aminopropane Hydrochloride (DOI) Improves Voiding Efficiency in the Diabetic Rat

Protective effect of novel CB1 receptor antagonist ZH-101-S on renal function in diabetic rats

Specialized pro-resolution mediators in the bladder: effects of resolvin E1 on diabetic bladder dysfunction in the type 1 diabetic male Akita mouse model

Differentially Expressed mRNA in Streptozotocin-Induced Diabetic Bladder Using RNA Sequencing Analysis

Pathophysiological changes of the lower urinary tract behind voiding dysfunction in streptozotocin-induced long-term diabetic rats